BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32674137)

  • 1. TCR-Seq Identifies Distinct Repertoires of Distant-Metastatic and Nondistant-Metastatic Thyroid Tumors.
    Lan X; Cao J; Ye K; Zhang C; Zhang Q; Ge X; Wang C; Zhang C; Tai Z; Wei W; Huang Y; Yi X; Tan Z; Zheng C; Chen C; Zhu X; Wang J; Xu J; Zhu X; Ge M
    J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32674137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T Cell Receptor Beta-Chain Profiling of Tumor Tissue, Peripheral Blood and Regional Lymph Nodes From Patients With Papillary Thyroid Carcinoma.
    Wang Y; Liu Y; Chen L; Chen Z; Wang X; Jiang R; Zhao K; He X
    Front Immunol; 2021; 12():595355. PubMed ID: 33679738
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment.
    Guo M; Chen Z; Li Y; Li S; Shen F; Gan X; Feng J; Cai W; Liu Q; Xu B
    Front Endocrinol (Lausanne); 2021; 12():674616. PubMed ID: 34248843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal miRNAs are potential diagnostic biomarkers between malignant and benign thyroid nodules based on next-generation sequencing.
    Pan Q; Zhao J; Li M; Liu X; Xu Y; Li W; Wu S; Su Z
    Carcinogenesis; 2020 Mar; 41(1):18-24. PubMed ID: 31560760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic landscape of metastatic papillary thyroid carcinoma and novel biomarkers for predicting distant metastasis.
    Lan X; Bao H; Ge X; Cao J; Fan X; Zhang Q; Liu K; Zhang X; Tan Z; Zheng C; Wang A; Chen C; Zhu X; Wang J; Xu J; Zhu X; Wu X; Wang X; Shao Y; Ge M
    Cancer Sci; 2020 Jun; 111(6):2163-2173. PubMed ID: 32187423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted next-generation sequencing in papillary thyroid carcinoma patients looking for germline variants predisposing to the disease.
    Shen CT; Zhang GQ; Qiu ZL; Song HJ; Sun ZK; Luo QY
    Endocrine; 2019 Jun; 64(3):622-631. PubMed ID: 30826992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of differentially expressed genes and long non-coding RNAs in papillary thyroid carcinoma diagnosis, progression, and prognosis.
    Cai WY; Chen X; Chen LP; Li Q; Du XJ; Zhou YY
    J Cell Biochem; 2018 Nov; 119(10):8249-8259. PubMed ID: 29968931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal Distribution and Intratumor Heterogeneity of the TCR Repertoire in Papillary Thyroid Cancer With or Without Coexistent Hashimoto's Thyroiditis.
    Cui L; Zhang C; Ding H; Feng D; Huang H; Lu Z; Liu B
    Front Immunol; 2022; 13():821601. PubMed ID: 35720279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence.
    He J; Tian Z; Yao X; Yao B; Liu Y; Yang J
    Clin Exp Metastasis; 2020 Apr; 37(2):257-267. PubMed ID: 31792675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
    Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
    Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-Exome Sequencing of Matched Primary and Metastatic Papillary Thyroid Cancer.
    Masoodi T; Siraj AK; Siraj S; Azam S; Qadri Z; Albalawy WN; Parvathareddy SK; Al-Sobhi SS; Al-Dayel F; Alkuraya FS; Al-Kuraya KS
    Thyroid; 2020 Jan; 30(1):42-56. PubMed ID: 31668133
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhanced expression of Cyclin D1 and C-myc, a prognostic factor and possible mechanism for recurrence of papillary thyroid carcinoma.
    Sanjari M; Kordestani Z; Safavi M; Mashrouteh M; FekriSoofiAbadi M; Ghaseminejad Tafreshi A
    Sci Rep; 2020 Mar; 10(1):5100. PubMed ID: 32198408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interinstitutional variation in predictive value of the ThyroSeq v2 genomic classifier for cytologically indeterminate thyroid nodules.
    Marcadis AR; Valderrabano P; Ho AS; Tepe J; Swartzwelder CE; Byrd S; Sacks WL; Untch BR; Shaha AR; Xu B; Lin O; Ghossein RA; Wong RJ; Marti JL; Morris LGT
    Surgery; 2019 Jan; 165(1):17-24. PubMed ID: 30360906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines.
    Wang Y; Bhandari A; Niu J; Yang F; Xia E; Yao Z; Jin Y; Zheng Z; Lv S; Wang O
    Hum Cell; 2019 Jul; 32(3):334-342. PubMed ID: 30805847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-146b measurement in FNA to distinguish papillary thyroid cancer from benign thyroid masses.
    Yang F; Zhang H; Leng X; Hao F; Wang L
    Br J Biomed Sci; 2018 Jan; 75(1):43-45. PubMed ID: 28937915
    [No Abstract]   [Full Text] [Related]  

  • 16. Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma-Do They Exist?
    Szpak-Ulczok S; Pfeifer A; Rusinek D; Oczko-Wojciechowska M; Kowalska M; Tyszkiewicz T; Cieslicka M; Handkiewicz-Junak D; Fujarewicz K; Lange D; Chmielik E; Zembala-Nozynska E; Student S; Kotecka-Blicharz A; Kluczewska-Galka A; Jarzab B; Czarniecka A; Jarzab M; Krajewska J
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Afirma Gene Sequencing Classifier Compared with Gene Expression Classifier in Indeterminate Thyroid Nodules.
    Endo M; Nabhan F; Porter K; Roll K; Shirley LA; Azaryan I; Tonkovich D; Perlick J; Ryan LE; Khawaja R; Meng S; Phay JE; Ringel MD; Sipos JA
    Thyroid; 2019 Aug; 29(8):1115-1124. PubMed ID: 31154940
    [No Abstract]   [Full Text] [Related]  

  • 18. SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms.
    He J; Zhou M; Li X; Gu S; Cao Y; Xing T; Chen W; Chu C; Gu F; Zhou J; Jin Y; Ma J; Ma D; Zou Q
    Oncogene; 2020 Mar; 39(13):2658-2675. PubMed ID: 32005974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal High-Throughput Sequencing of the T-Cell Receptor Repertoire Reveals Dynamic Change and Prognostic Significance of Peripheral Blood TCR Diversity in Metastatic Colorectal Cancer During Chemotherapy.
    Chen YT; Hsu HC; Lee YS; Liu H; Tan BC; Chin CY; Chang IY; Yang CY
    Front Immunol; 2021; 12():743448. PubMed ID: 35095836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognosis of Papillary Thyroid Cancer with Initial Distant Metastasis is Strongly Associated with Extensive Extrathyroidal Extension: A Retrospective Cohort Study.
    Lee YK; Kim D; Shin DY; Lee CR; Lee EJ; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY; Park CS
    Ann Surg Oncol; 2019 Jul; 26(7):2200-2209. PubMed ID: 30895495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.